KEGG pathways |
hsa04060 |
Cytokine–cytokine receptor interaction |
4 |
.0100043 |
hsa05144 |
Malaria |
2 |
.0110871 |
hsa05214 |
Glioma |
2 |
.0186208 |
hsa05212 |
Pancreatic cancer |
2 |
.0191468 |
hsa05218 |
Melanoma |
2 |
.0218693 |
hsa04540 |
Gap junction |
2 |
.0328786 |
hsa05215 |
Prostate cancer |
2 |
.0328786 |
hsa05323 |
Rheumatoid arthritis |
2 |
.0342118 |
hsa05142 |
Chagas disease (American trypanosomiasis) |
2 |
.0433727 |
hsa04010 |
MAPK signaling pathway |
3 |
.0477863 |
Reactome |
REACT_118779 |
Extracellular matrix organization |
7 |
2.56E‐07 |
REACT_163874 |
Non‐integrin membrane‐ECM interactions |
7 |
3.77E‐07 |
REACT_163906 |
ECM proteoglycans |
9 |
1.77E‐05 |
REACT_318 |
Platelet degranulation |
6 |
4.38E‐04 |
REACT_6323 |
Host Interactions with Influenza Factors |
4 |
4.06E‐03 |
REACT_1280 |
Response to elevated platelet cytosolic Ca2+ |
11 |
2.37E‐06 |
REACT_120996 |
Hyaluronan uptake and degradation |
11 |
4.70E‐05 |
REACT_120726 |
TGF‐beta receptor signaling in EMT (epithelial to mesenchymal transition) |
6 |
7.15E‐04 |
REACT_121083 |
Hyaluronan metabolism |
4 |
3.05E‐03 |
REACT_115852 |
Signaling by constitutively active EGFR |
6 |
4.77E‐03 |
PID |
il27pathway |
IL27‐mediated signaling events |
2 |
.0051456 |
ceramide_pathway |
Ceramide signaling pathway |
2 |
.0134937 |
pdgf_pathway |
PDGF receptor signaling network |
1 |
.0267852 |
telomerasepathway |
Regulation of Telomerase |
2 |
.0289511 |
ap1_pathway |
AP‐1 transcription factor network |
2 |
.0313181 |
et_egfrpathway |
EGFR‐dependent Endothelin signaling events |
1 |
.0380509 |
erbb_network_pathway |
ErbB receptor signaling network |
1 |
.0602047 |
syndecan_1_pathway |
Syndecan‐1‐mediated signaling events |
1 |
.0674790 |
rxr_vdr_pathway |
RXR and RAR heterodimerization with other nuclear receptor |
1 |
.0995446 |
alk1pathway |
ALK1 signaling events |
1 |
.0995446 |